Clinical characteristics of gastrointestinal lymphomas associated with AIDS (GI-ARL) and the impact of HAART

HIV Clinical Trials

Volumn 5, Issue 3, 2004, Pages 140-145

  Srinivasan, Sridhar ^a   Takeshita, Kenichi ^b   Holkova, Beata ^a   Czuczman, Myron S ^c   Miller, Kena ^c   Bernstein, Zale P ^c   Driscoll, Deborah ^c   Chanan Khan, Asher ^c  

^a UNIVERSITY AT BUFFALO   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Gastrointestinal; HAART; HIV; Lymphoma

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; GASTROINTESTINAL TRACT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; KAPLAN MEIER METHOD; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES; VISCERAL METASTASIS;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; MEDICAL RECORDS; MIDDLE AGED; NEW YORK; NEW YORK CITY; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 4344633087     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/BDHX-D9BC-YWVU-9NBR     Document Type: Article

References (26)

1. Maso LD, Franceschi S. Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol. 2003;4:110-119.
2. Ziegler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med. 1984;311:565-570.
3. Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood. 1992;80:8-20.
4. Wang CY, Snow JL, Su WP. Lymphoma associated with human immunodeficiency virus infection. Mayo Clin Proc. 1995;70:665-672.
5. Parente F, Rizzardini G, Cernuschi M, et al. Non-Hodgkin's lymphoma and AIDS: frequency of gastrointestinal involvement in a large Italian series. Scand J Gastroenterol. 1993;28:315-318.
6. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-860.
7. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst. 2000;92:1823-1830.
8. Grulich AE, Li Y, McDonald AM, et al. Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy. AIDS. 2001;15:629-633.
9. Carrieri MP, Pradier C, Piselli P, et al. Reduced incidence of Kaposi's sarcoma and of systemic non-Hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Int J Cancer. 2003;103:142-144.
10. Gerard L, Galicier L, Maillard A, et al. Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival. J Acquir Immune Defic Syndr. 2002;30:478-484.
11. Antinori A, Cingolani A, Alba L, et al. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS. 2001;15:1483-1491.
12. Tam HK, Zhang ZF, Jacobson LP, et al. Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. Int J Cancer. 2002;98:916-922.
13. Holkova B, Takeshita K, Cheng DM, et al. Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy. J Clin Oncol. 2001;19:3848-3851.
14. Chanan-Khan A, Holkova B, Dmopoulos R, et al. Changing epidemiology of AIDS related non-Hodgkin's lymphoma (ARL) in the era of highly active anti-retroviral therapy: experience at a municipal hospital in New York City. J Clin Oncol. 2002;21(1):289a.
15. Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol. 2001;19:3861-3873.
16. Crump M, Gospodarowicz M, Shepherd FA. Lymphoma of the gastrointestinal tract. Semin Oncol. 1999;26:324-337.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statistics Assoc. 1958;53:457-486.
18. Imrie KR, Sawka CA, Kutas G, et al. HIV-associated lymphoma of the gastrointestinal tract: the University of Toronto AIDS-Lymphoma Study Group experience. Leuk Lymphoma. 1995;16:343-349.
19. Heise W, Arasteh K, Mostertz P, et al. Malignant gastrointestinal lymphomas in patients with AIDS. Digestion. 1997;58:218-224.
20. Levine AM, Seneviratne L, Espina BM, et al. Evolving characteristics of AIDS-related lymphoma. Blood. 2000;96:4084-4090.
21. Gill PS, Levine AM, Krailo M, et al. AIDS-related malignant lymphoma: results of prospective treatment trials. J Clin Oncol. 1987;5:1322-1328.
22. Scadden DT. AIDS-related malignancies. Annu Rev Med. 2003;54:285-303.
23. Otter R, Bieger R, Kluin PM, et al. Primary gastrointestinal non-Hodgkin's lymphoma in a population-based registry. Br J Cancer. 1989;60:745-750.
24. d'Amore F, Brincker H, Gronbaek K, et al. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. J Clin Oncol. 1994;12:1673-1684.
25. Straus DJ, Huang J, Testa MA, et al. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142 - low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases. J Clin Oncol. 1998;16:3601-3606.
26. Straus DJ. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma. Recent Results Cancer Res. 2002;159:143-148.